Wockhardt Ltd. (WOCKPHARMA) Share Price Rise Streak: Stock extends fourth consecutive session

Wockhardt Ltd. Share Price is Rs 2,152.40, up 3.15% today, with market capitalisation at Rs 33,908.05 crore. The stock is in its fourth consecutive session higher.

Wockhardt Ltd. Share Price has now risen for the fourth consecutive session, with a cumulative gain of 16.29% from the streak base of Rs 1,850.85. The latest move confirms the pattern, but the available market data does not establish a company-specific catalyst. For readers tracking Wockhardt Ltd. Share Price Today, the point is not only the latest session but the steady sequence of higher closes that has kept WOCKPHARMA in focus across Univest and broader Stocks in News screens.

Wockhardt Ltd. Share Price Rise Streak: Consecutive Gain Analysis

Against the previous close of Rs 2,086.75, the stock last traded at Rs 2,152.40 after opening at Rs 2,122.25. It moved between Rs 2,079.00 and Rs 2,158.95 during the morning trade, while turnover stood at Rs 9.13 crore and market capitalisation at Rs 33,908.05 crore. A four-session run matters differently from a single-day gain because it shows persistence in price action, not just one swing, and that is why Wockhardt Ltd. Share Price Rise Streak is attracting attention in the Indian stock market today.

Wockhardt Ltd. (WOCKPHARMA) rose to Rs 2,152.4 from the previous close of Rs 2,086.75, a move of Rs 65.65 or 3.15%. The stock opened at Rs 2,122.25, reached a high of Rs 2,158.95, recorded a low of Rs 2,079.

Wockhardt Ltd. Share Price Today reflects another higher session, with the stock trading Rs 65.65 above the previous close of Rs 2,086.75, a rise of 3.15%. The current price of Rs 2,152.40 also sits near the upper end of the day’s range, which ran from Rs 2,079.00 to Rs 2,158.95.

The opening price of Rs 2,122.25 showed an early start above the previous close, and the move held through the session as the stock stayed constructive in price action. Turnover at Rs 9.13 crore shows active market interest, while the market cap of Rs 33,908.05 crore places the company among sizeable healthcare names. For readers following Wockhardt Ltd. Share Price Rise Streak on Univest, the key observation is simple: the latest session extended a broader sequence rather than standing alone.

What the Consecutive Gains Show

This pattern suggests that traders have continued to reprice the stock across successive sessions, even though the market data does not point to a verified catalyst. That distinction matters. Univest readers can treat the streak as a factual market event, then evaluate whether the move is being supported by valuation and business quality rather than assuming a fresh company trigger.

Wockhardt Ltd. (WOCKPHARMA) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 33,908.05 crore
P/E Ratio	82.9x
P/B Ratio	6.74x
ROE	4.29%
ROCE	6.79%
EPS	Rs 25.17
Book Value Per Share	Rs 309.81
Dividend Yield	0%

Wockhardt Ltd. (WOCKPHARMA) fundamental metrics show P/E 82.9x, P/B 6.74x, ROE 4.29%, ROCE 6.79%. These figures provide context only and are not a buy or sell signal.

Wockhardt Ltd. has a market capitalisation of Rs 33908.05 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 82.9x, P/B at 6.74x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 4.29% and ROCE of 6.79%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 25.17, book value per share of Rs 309.81, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.83x, median ROE of 11.78%, median ROCE of 13.65%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	82.9x
Benchmark Median P/E	32.83x
Benchmark Average P/E	48.79x
Benchmark P/E Range	3.2x to 659.73x
Company P/B Ratio	6.74x
Benchmark Median P/B	2.92x
Company ROE	4.29%
Benchmark Median ROE	11.78%
Company ROCE	6.79%
Benchmark Median ROCE	13.65%
Company Market Capitalisation	Rs 33,908.05 crore
Benchmark Median Market Cap	Rs 674.09 crore

Wockhardt Ltd. (WOCKPHARMA) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Wockhardt Ltd. (WOCKPHARMA) has a P/E ratio of 82.9x, which is above the benchmark median of 32.83x, a difference of +152.51%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Wockhardt Ltd. (WOCKPHARMA) has a ROE of 4.29%, which is below the benchmark median of 11.78%, a difference of -63.58%. Wockhardt Ltd. (WOCKPHARMA) has a ROCE of 6.79%, which is below the benchmark median of 13.65%, a difference of -50.26%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries Ltd.	SUNPHARMA	4,55,633.71	37.67	5.27	14.85	19.11
Divi's Laboratories Ltd.	DIVISLAB	2,41,576.41	82.59	13.68	16.19	21.51
Torrent Pharmaceuticals Ltd.	TORNTPHARM	1,84,478.41	84.58	20.55	26.76	19.27
Cipla Ltd.	CIPLA	1,11,888.39	33.19	3.18	11.83	16
Zydus Lifesciences Ltd.	ZYDUSLIFE	1,11,820.18	24.78	4.15	19.69	21.39

Wockhardt Ltd. (WOCKPHARMA) has a P/E ratio of 82.9x compared with the displayed peer median of 37.67x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 4.29% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 6.79% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Wockhardt Ltd. (WOCKPHARMA) has a market capitalisation of Rs 33,908.05 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Why Investors Are Watching Wockhardt

• Wockhardt Ltd. Share Price Rise Streak has continued into a fourth consecutive session, keeping price action in focus.
• The latest move added 3.15% on the day, with the stock last trading at Rs 2,152.40.
• Market capitalisation stands at Rs 33,908.05 crore, giving the company meaningful size in healthcare.
• Valuation is elevated versus the same-industry median, with a P/E of 82.9 and a P/B of 6.74.
• Investors can use Univest to track Wockhardt Ltd. Share Price, financial ratios and sector comparison in one place.

About Wockhardt

Wockhardt Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The business is known for pharmaceutical products, and its market presence is reflected in the Rs 33,908.05 crore market capitalisation seen today. Wockhardt Ltd. Share Price is therefore being tracked not just as a market move but as a reflection of how investors are pricing the company within a competitive drug manufacturing space.

For readers using Wockhardt Ltd. Share Price Rise Streak as an entry point, the company’s fundamental profile matters because the stock is trading at a high P/E and P/B versus industry benchmarks. That makes business quality, earnings capacity and capital efficiency important context. Univest presents the share price alongside the company’s financial analysis so readers can connect the business model with the market reaction.

Frequently Asked Questions

Why is Wockhardt Ltd. Share Price rising today?

Ans. The latest market data confirms a 3.15% rise and a fourth consecutive session higher, but it does not establish a company-specific catalyst. Readers should separate the verified price pattern from any assumed trigger.

What is Wockhardt Ltd. Share Price today?

Ans. Wockhardt Ltd. Share Price was Rs 2,152.40 in morning trade, after moving above the previous close of Rs 2,086.75. The stock stayed near the top of the day’s range, showing firm intraday price action.

How much has Wockhardt moved across the streak?

What does the latest Wockhardt price action show?

Ans. The stock opened at Rs 2,122.25, touched Rs 2,158.95 and saw a low of Rs 2,079.00. Trading near the upper band of that range suggests sustained interest through the morning session.

Is Wockhardt expensive compared with the industry?

Ans. Wockhardt trades at a P/E of 82.9 and P/B of 6.74, both above the same-industry medians of 32.83 and 2.92. That places the stock at a premium to the broader Pharmaceuticals & Drugs set.

How do Wockhardt’s returns compare with peers?

Ans. Wockhardt’s ROE of 4.29% and ROCE of 6.79% are below the benchmark medians and many named peers. That creates a gap between valuation and operating returns that investors may want to note.

What is Wockhardt’s market capitalisation?

Ans. Wockhardt’s market capitalisation stands at Rs 33,908.05 crore. That gives the company size in the healthcare universe, although market cap alone does not tell investors whether valuation is justified.

Where can investors track Wockhardt Ltd. Share Price on Univest?

Ans. Investors can track Wockhardt Ltd. Share Price on Univest for live price movement, valuation ratios, EPS, book value, market cap and sector comparison. It is useful for following the stock alongside Wockhardt Ltd. Stock News.

Track Wockhardt Ltd. Share Price on Univest

Use Wockhardt Ltd. (WOCKPHARMA) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

On Univest, readers can track Wockhardt Ltd. Share Price Live alongside key ratios such as P/E, P/B, ROE, ROCE, EPS, book value and market capitalisation. The same page also helps users follow Wockhardt Ltd. Stock News, Wockhardt Ltd. News Today, Wockhardt Ltd. Share Price Update and broader market insights in a single view.

For investors comparing Wockhardt Ltd. Share Price Today with peers, Univest makes it easier to review sector context, company overview and valuation in one place. That keeps the discussion focused on facts rather than speculation.